Alpha Teknova, Inc. will report its financial results for the second quarter ended June 30, 2026, on Wednesday, August 5, 2026, following the close of market. The announcement will provide insights into the company's performance for the quarter, covering its production of critical reagents for the life sciences industry.

To discuss the results, Teknova will host a conference call and webcast on August 5, 2026, beginning at 6:00 p.m. Eastern Time. Investors can access the live webcast through the Investor Relations section of the Teknova website or via a direct link provided by the company. Those wishing to participate in the call must register for the webcast to receive a unique PIN number and dial-in details.

A replay of the webcast will be available on the company’s website approximately two hours after the event concludes. This allows stakeholders who cannot attend the live session to access the discussion at their convenience.

Teknova specializes in manufacturing critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Headquartered in Hollister, California, the company supports industry leaders in genomics, molecular diagnostics, and emerging therapeutic modalities with customizable solutions.

For inquiries, Matt Lowell, Chief Financial Officer, serves as the primary investor contact, while Jennifer Henry, Senior Vice President, Marketing, handles media communications.